Ben Strain

Ben Strain is an accomplished professional in investor relations, currently serving as the Head of Investor Relations at Incyte since September 2023. Prior to this role, Ben held various senior positions at Foghorn Therapeutics, Inc., and Paratek Pharmaceuticals, where responsibilities included developing strategic investor relations plans and managing corporate communications. Ben's tenure at Biogen included significant contributions to a top-ranked investor relations department, enhancing presentation formats, and coordinating corporate messaging. Previous experience includes roles at Under Armour and The Boston Company Asset Management, LLC, where Ben gained expertise in equity analysis and investor communications. Ben holds an MBA from Bentley University and a Bachelor of Science in Economics from UNH.